WebGlobal Head of Business Development, Neurology, Rare Diseases & Technology Platforms . Matthieu Lebrun. Global Head of Business Development, Out-Licensing . Donna Martin. Global Head of Business Development, Vaccines . Matthieu Merlin. Global Head of Business Development, General Medicines. WebMar 9, 2024 · William Shen, former Biogen and BMS BD executive, joins as Chief Business Officer [09-March-2024] CAMBRIDGE, Mass. , March 9, 2024 /PRNewswire/ -- Orna …
BioCentury - Viehbacher assessing BD as Biogen ‘rebalances’ risk ...
WebApr 4, 2024 · CAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the appointment of Adam Keeney, Ph.D., as Executive … WebFeb 15, 2024 · Viehbacher assessing BD as Biogen ‘rebalances’ risk, reward in pipeline With launches looming and chairman likely to retire, new CEO eyes shorter timelines to proof of concept, will mull bringing in assets via deals ... rare diseases or psychiatry. The company is looking to hire a head of business development, as well as a head of … how to talk with a raspy voice
Home Biogen
WebSep 17, 2024 · Biogen has a new R&D leader, announcing Tuesday that Michael Ehlers will leave on Oct. 11 and, effective immediately, pass his duties on to Chief Medical Officer … WebCorporate Governance. Leadership Team. Extended Leadership Team. Board of Directors. Caring deeply. Working fearlessly. Changing lives. Information for. Medical Professionals. WebBiogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, … real abstract staten island